TP53 and breast carcinoma: Moreover, we compared the advanced-stage breast cancer cases in our cohort and the MSKCC dataset and found three genes (TP53, KMT2C, and KMT2D) with a higher mutation frequency in our cohort and one gene (ESR1) with a lower mutation frequency in our dataset (Fig. 3c).